Jump to content
MMS/NEJM Continuing Education Center
Search
Open menu
Cart
Register
Bookmark/Search this post
Facebook
Twitter
LinkedIn
Forward
My CE Activities & Profile
Pending Courses
Transcript/Certificates
View CE Profile
MMS CE
NEJM Group CE
Resources
Accreditation
Joint Providership
CME Accreditation for Institutions
About
Contact us
My Account
Create Account
Sign In
You are here
Home
»
NEJM Weekly CME
»
Empagliflozin in Patients with Chronic...
Empagliflozin in Patients with Chronic Kidney Disease
Empagliflozin in Patients with Chronic Kidney Disease
Overview
Accreditation
Register/Take course
Original Article
The EMPA-KIDNEY Collaborative Group
N Engl J Med 2023;388:117-127
Course summary
Available credit:
1.00
AMA PRA Category 1 Credit
™
1.00
Participation
Course opens:
01/11/2023
Course expires:
01/12/2025
Available Credit
1.00
AMA PRA Category 1 Credit
™
1.00
Participation
Course closed
This course closed on
Sunday, January 12, 2025 - 11:59pm
.
Search
My CE Activities & Profile
Pending Courses
Transcript/Certificates
View CE Profile
MMS CE
NEJM Group CE
Resources
Accreditation
Joint Providership
CME Accreditation for Institutions
About
Contact us
My Account
Create Account
Sign In